Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
G. MacGrogan
Based on 10 articles published since 2009
(Why 10 articles?)
||||
Expertise Level
The expertise of G. MacGrogan ranks in the
  • Top 1.3%
  • ... of 264,224 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 10 articles on the topic.
Graphical view (beta)
Work Locations
Details
Most likely:    INSERM France      
2016
  • Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U916, INSERM CIC1401, Bordeaux · Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U916, INSERM CIC1401, Bordeaux. · Department of Medical Oncology, Centre Léon Bérard, Lyon. · Department of Medical Oncology, Breast Cancer Unit, Gustave Roussy, Villejuif. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse. · Department of Breast Cancer, Centre Oscar Lambret, Lille. · Department of Medical Oncology, Centre Hospitalier Départemental Vendée, La Roche sur Yon. · Department of Medical Oncology, Institut Curie, PSL Research University, Paris. · Department of Medical Oncology, Centre Paul Papin, Angers. · Department of Medical Oncology, Teaching Hospital, Lyon-Sud University, Lyon. · Department of Medical Oncology, CHU Grenoble, Grenoble. · Department of Medical Oncology, Centre Hospitalier Layné, Mont-de-Marsan. · Department of Gynecologic Surgery, Hôpital du Leman, Thonon-Les-Bains. · Department of Medical Oncology, Centre GF Leclerc, Dijon. · Department of Medical Oncology, Institut Curie, St Cloud. · Department of Medical Oncology, Institut Sainte-Catherine, Avignon. · Department of Pathology, Institut Bergonié, INSERM U916, Bordeaux. · UNICANCER R&D, Paris. · Clinical and Epidemiological Research Unit, Institut Bergonié, INSERM CIC1401, Bordeaux. · Department of Medical Oncology, Institut Paoli-Calmettes, Cancer Research Center of Marseille, INSERM U7258, CNRS U1068, Aix-Marseille Université, Marseille, France. · Pubmed 27052658
2014
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
Probable:    Universite de Bordeaux      
2014
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by G. MacGrogan in 2009-2019 about Breast Neoplasms:

  • A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1). 2016
  • Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. 2015
  • Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration. 2015
  • Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial. 2015
  • Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial. 2014
  • Endocrine-responsive breast cancer special types: who cares? 2012
  • Docetaxel rechallenge after a first response in non-resistant metastatic breast cancer: significant activity with manageable toxicity. 2012
  • A refined molecular taxonomy of breast cancer. 2012
  • Phase III randomized equivalence trial of early breast cancer treatments with or without axillary clearance in post-menopausal patients results after 5 years of follow-up. 2011
  • Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial. 2011
Show List of Full Article Records
Google Searches

Learn more about G. MacGrogan using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
INSERM France
Universite de Bordeaux
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
INSERM France
2016
  • Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U916, INSERM CIC1401, Bordeaux · Department of Medical Oncology, Institut Bergonié Unicancer, Univ. Bordeaux, INSERM U916, INSERM CIC1401, Bordeaux. · Department of Medical Oncology, Centre Léon Bérard, Lyon. · Department of Medical Oncology, Breast Cancer Unit, Gustave Roussy, Villejuif. · Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse. · Department of Breast Cancer, Centre Oscar Lambret, Lille. · Department of Medical Oncology, Centre Hospitalier Départemental Vendée, La Roche sur Yon. · Department of Medical Oncology, Institut Curie, PSL Research University, Paris. · Department of Medical Oncology, Centre Paul Papin, Angers. · Department of Medical Oncology, Teaching Hospital, Lyon-Sud University, Lyon. · Department of Medical Oncology, CHU Grenoble, Grenoble. · Department of Medical Oncology, Centre Hospitalier Layné, Mont-de-Marsan. · Department of Gynecologic Surgery, Hôpital du Leman, Thonon-Les-Bains. · Department of Medical Oncology, Centre GF Leclerc, Dijon. · Department of Medical Oncology, Institut Curie, St Cloud. · Department of Medical Oncology, Institut Sainte-Catherine, Avignon. · Department of Pathology, Institut Bergonié, INSERM U916, Bordeaux. · UNICANCER R&D, Paris. · Clinical and Epidemiological Research Unit, Institut Bergonié, INSERM CIC1401, Bordeaux. · Department of Medical Oncology, Institut Paoli-Calmettes, Cancer Research Center of Marseille, INSERM U7258, CNRS U1068, Aix-Marseille Université, Marseille, France. · Pubmed 27052658
2014
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
Unspecified
2015
  • Biostatistic Unit, Montpellier Cancer Institute, Montpellier Data Center for Cancer Clinical Trials, CTD-INCa, Montpellier, France · Edinburgh Cancer Research Centre, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Department of Radiation Oncology, Institute Verbeeten, Tilburg, The Netherlands. · Department of Biostatistics, Institut Curie, Paris. · Department of Radiation Oncology, Montpellier Cancer Institute, Montpellier, France. · Breast Cancer Unit, Champalimaud Cancer Center, Lisbon, Portugal. · Institute of Cancer Research, London, UK. · EORTC Data Center (European Organization of Research and Treatment of Cancer - Statistics Department), Brussels, Belgium. · Institut Bergonié, Comprehensive Cancer Centre, Bordeaux. · Departments of Clinical Research and Medical Oncology, Institut Curie - Hôpital René Huguenin, Saint-Cloud. · Department of Medical Oncology, Hôpital Saint-Antoine, Paris, France. · FRCP, FRCPE YCR National Institute for Health Research Cancer Research Network (NCRN), Academic Unit of Clinical Oncology, Weston Park Hospital, Sheffield Cancer Research Centre, Sheffield, UK. · University Clinic Golnik, Golnik, Slovenia. · Institut Jules Bordet, University 'Libre' of Brussels, Brussels, Belgium. · Institut Claudius Régaud, Toulouse. · Breast Cancer Group, Gustave Roussy Institute, Villejuif. · APHP Tenon - University Cancer Institute - Pierre & Marie Curie, Sorbonne University, Paris. · Department of Surgery. · Department of Medical Oncology, Montpellier Cancer Institute, Montpellier, France. · Université catholique Louvain, Louvain-la-Neuve, Belgium. · Biostatistic and Epidemiology Unit, Gustave Roussy, Villejuif University of Paris-Sud, Villejuif, France. · Breast Unit, Hospital CUF Descobertas, Lisbon, Portugal. · Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. · Centre Jean Perrin, Clermont-Ferrand ERTICA EA4677, UFR Medicine, University of Clermont-Ferrand 1, Clermont-Ferrand, France. · European Institute of Oncology, Milan University of Milan, School of Medicine, Milan, Italy. · Department of Radiotherapy, The Netherlands Cancer Institute - Antoni van Leeuwnhoek Hospital, Amsterdam, The Netherlands. · IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto), Porto Medical Faculty of Porto University, Porto, Portugal. · Oscar Lambret Comprehensive Cancer Center, Lille, France. · Kantonsspital St Gallen, Breast Center, St Gallen, Switzerland. · Clinic for Gynecology, Gynecologic Oncology and Obstetrics-Interdisciplinary Breast Cancer Center, HELIOS Klinikum Berlin-Buch, Berlin, Germany. · Department of Surgical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam. · Academic Medical Center Amsterdam, Amsterdam, The Netherlands. · Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven Laboratory of Experimental Oncology (LEO), Department of Oncology, KU Leuven, Leuven, Belgium. · The Institute of Cancer Research, Royal Cancer Hospital, London, UK. · Methodological and Quality of Life Unit in Oncology (EA3181), CHU Besançon, Besançon. · Clinical and Epidemiological Research Unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux Clinical Epidemiology Unit, INSERM CIC 14.01 (Clinical Epidemiology), Bordeaux. · Biostatistics and Quality of Life Unit (EA4184), Centre Georges François Leclerc Comprehensive Cancer Centre, Dijon, France. · Pubmed 25725046
  • Department of Pathology, Yale University, New Haven, USA · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK. · Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston. · Division of Subspecialty General Surgery, Mayo Clinic, Rochester, USA. · Oncology Centre, Cambridge University Hospitals National Health Services Foundation Trust, Cambridge, UK. · Division of Early Drug Development for Innovative Therapies, European Institute of Oncology, Milan, Italy. · Edinburgh Breast Unit, Western General Hospital, Edinburgh, UK. · Carol Franc Buck Breast Care Center, University of California, San Francisco, USA. · Department of Radiotherapy and Radiation Oncology, Landeskrankenhaus, Paracelsus Medical University, Salzburg, Austria. · Department of Gynecology and Obstetrics, Interdisciplinary Breast Center, Klinikum Esslingen, Essligen, Germany. · Institute of Pathology, Medical University of Graz, Graz Breast Center Salzburg, Paracelsus Medical University, University Hospital Salzburg, Salzburg, Austria. · German Breast Group, Neu-Isenburg, and University Women's Hospital, Frankfurt, Germany. · Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, Houston. · Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, USA. · Institute of Pathology, Charité Hospital, Campus Mitte, Berlin, Germany. · Department of Biopathology, Institut Bergonié, Bordeaux. · Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France. · Department of Pathology, European Institute of Oncology and University of Milan, Milan, Italy. · Edinburgh Cancer Research UK Centre, The University of Edinburgh, Edinburgh, UK. · Pubmed 26019189
  • Division of Medical Senology, European Institute of Oncology, Milan, Italy · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA. · Institute of Cancer Sciences, Glasgow University, Glasgow. · Southern General Hospital, Glasgow, UK. · Department of Pathology and Laboratory Medicine, IBCSG Central Pathology Laboratory, European Institute of Oncology, and University of Milan, Milan, Italy. · Breast Center, Kantonsspital, St Gallen Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland. · Danish Breast Cancer Cooperative Group (DBCG), Rigshospitalet, Copenhagen, Denmark. · Department of Pathology, Institut Bergonié, Bordeaux. · Department of Pathology, Val d'Aurelle Cancer Institute, Montpellier, France. · Department of Pathology, Rigshospitalet, Copenhagen, Denmark. · International Breast Cancer Study Group (IBCSG) Statistical Center. · Department of Biostatistics and Computational Biology, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute, Boston, USA Harvard T.H. Chan School of Public Health, Harvard Medical School, Frontier Science and Technology Research Foundation, Boston, USA. · International Breast Cancer Study Group, Bern, Switzerland University of Sydney, Sydney, Australia. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Division of Medical Senology, European Institute of Oncology, Milan, Italy. · Pubmed 26387144
Universite de Bordeaux
2014
  • Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France · European Organisation for Research and Treatment of Cancer (EORTC), Brussels. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Bergonié Comprehensive Cancer Centre, Université de Bordeaux, INSERM U916, Bordeaux, France. · Centre George-François Leclerc, Dijon. · Ensemble Hospitalier de L'Institut Curie, Hopital René Huguenin, St-Cloud. · Centre Paul Strauss, Strasbourg. · Centre Val D'Aurelle-Paul Lamarque, Montpellier, France. · Medical University, Gdansk, Poland. · Centre Henri Becquerel, Rouen, France. · Geneva University Hospital, Geneva Swiss Group for Clinical Cancer Research (SAKK), Bern. · Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. · Institute of Oncology, Ljubljana University Clinic Golnik, Golnik, Slovenia. · Institut de Cancérologie de L'Ouest (ICO), Centre René Gauducheau, Nantes Centre Paul Papin, Angers. · Centre Alexis Vautrin, Nancy, France. · Department of Clinical Sciences, Lund University, Lund Skåne Department of Oncology, Skåne University Hospital, Lund. · Swedish Breast Cancer Group (SweBCG), Stockholm Department of Oncology, Karolinska Institutet, Radiumhemmet and Karolinska University Hospital, Stockholm, Sweden. · Cancer Services, Edinburgh University Anglo-Celtic Cooperative Oncology Group (ACCOG), Edinburgh, UK. · Pubmed 24618153
4 Other Locations Show
Yearly article counts 00013103200
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.